Kaiman M, Shibata S
Arch Int Pharmacodyn Ther. 1977 Jul;228(1):23-9.
Phthalazinol (EG-626), a newly synthesized cyclic AMP phosphodiesterase inhibitor, inhibited spontaneous phasic contractions (SPC) of isolated rabbit portal veins in a dose-dependent manner. Phthalazinol at a minimal concentration necessary to completely abolish the SPC did not alter 45Ca-uptake, 45Ca-influx, or the ED50S for methoxamine (me) and K+, but it did reduce the amplitude of the tonic contractions induced by ME and K+ by approximately 25%. On the other hand, verapamil, and La+3 abolished SPC, ME, and K+-induced contractions. Tetrodotoxin had no effect on SPC or on tonic contractions induced by ME and K+. Since extracellular Ca++ is known to be essential for SPC, ME, and K+-induced contractions in rabbit portal vein, the present results suggest that the abolishment of SPC and the partial inhibition of the ME and K+ responses by phthalazinol may be related to an action of this agent on intracellular Ca++ or Ca++-efflux.
酞嗪醇(EG - 626)是一种新合成的环磷酸腺苷磷酸二酯酶抑制剂,它以剂量依赖性方式抑制离体兔门静脉的自发性节律性收缩(SPC)。完全消除SPC所需的最低浓度的酞嗪醇不会改变45Ca摄取、45Ca内流,或甲氧明(me)和K + 的半数有效剂量(ED50),但它确实使ME和K + 诱导的强直性收缩幅度降低了约25%。另一方面,维拉帕米和La + 3消除了SPC、ME和K + 诱导的收缩。河豚毒素对SPC或ME和K + 诱导的强直性收缩没有影响。由于细胞外Ca ++ 已知对兔门静脉中SPC、ME和K + 诱导的收缩至关重要,目前的结果表明,酞嗪醇对SPC的消除以及对ME和K + 反应的部分抑制可能与该药物对细胞内Ca ++ 或Ca ++ 外流的作用有关。